Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

Kroger to pay up to $1.4 billion to resolve US opioid lawsuits

Published 09/08/2023, 08:09 AM
Updated 09/08/2023, 01:50 PM
© Reuters. FILE PHOTO: Kroger logo is displayed in this illustration taken September 5, 2022. REUTERS/Dado Ruvic/Illustration/File Photo
KR
-
ACI
-

By Nate Raymond

(Reuters) -Kroger on Friday said it would pay as much as $1.4 billion to resolve thousands of lawsuits by U.S. states, local governments and Native American tribes claiming the supermarket chain's pharmacies helped fuel the nation's opioid epidemic.

Kroger (NYSE:KR) agreed to pay up to $1.2 billion to U.S. states, counties and municipalities and $36 million to Native American tribes to resolve the majority of opioid cases it faced. It will also pay $177 million to cover attorneys' fees and expenses.

Kroger took a $1.4 billion charge related to the tentative settlement, which is dependent on participation by 33 eligible states and the District of Columbia. The $1.2 billion would be paid out over 11 years.

The Cincinnati-based supermarket chain, which is seeking to merge with smaller rival Albertsons, will not admit wrongdoing as part of the deal, and said it will defend against any other claims the tentative settlement does not resolve.

The negotiations that produced the deal were led by attorneys general from California, Colorado, Illinois, North Carolina, Oregon, Tennessee and Virginia.

Thousands of lawsuits have been filed by states, local governments and Native American tribes accusing drug companies of downplaying the risks of opioid painkillers, and distributors and pharmacies of ignoring red flags that they were being trafficked illegally.

The litigation has resulted in more than $51 billion in settlements, according to lawyers for the plaintiffs, with deals already struck with major drugmakers and the nation's largest distributors.

Kroger itself faced more than 2,000 such lawsuits. In recent months, it had agreed to settle opioid claims by New Mexico for $58.5 million and West Virginia for $62 million.

"These dollars will help save lives, and we will make sure these companies can't repeat their mistakes," North Carolina Attorney General Josh Stein, who helped lead negotiations with Kroger, said in a statement.

Friday's settlement by Kroger followed a collective $13.8 billion in settlements reached last year with three larger pharmacy chain operators, CVS Health Corp (NYSE:CVS), Walgreens Boots Alliance (NASDAQ:WBA) and Walmart (NYSE:WMT).

In a statement on Friday, the lead lawyers representing cities and counties in the litigation - Jayne Conroy, Paul Farrell and Joe Rice - called Kroger's deal the first by one of the smaller, regional supermarket pharmacies that had played a role in the drug crisis.

© Reuters. FILE PHOTO: Traders work as screens display the trading information for Kroger Co and Albertsons Cos Inc. on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., October 14, 2022. REUTERS/Brendan McDermid/File Photo

"This $1.2 billion agreement-in-principle is another step forward in holding each company that played a role in the opioid epidemic accountable and ensuring hard-hit communities are provided with much-needed resources," the lawyers said.

Nearly 645,000 people died in the United States from overdoses involving opioids, both prescription and illicit, from 1999 to 2021, according to the U.S. Centers for Disease Control and Prevention.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.